Evidence map›Paper›PMID 30782994›Full record

ArticleAntimicrobial agents and chemotherapy2019

Iron/Heme Metabolism-Targeted Gallium(III) Nanoparticles Are Active against Extracellular and Intracellular

Seoung-Ryoung Choi, Bradley E Britigan, Prabagaran Narayanasamy

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Exploiting haem-iron dependence of nontypeableFrontiers in cellular and infection microbiology · 2025
    Review
  6. Article
  7. In Silico Analysis of the GaBiomolecules · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. FightingFrontiers in cellular and infection microbiology · 2021
    Review
  17. Metallotherapeutics development in the age of iron-clad bacteria.Metallomics : integrated biometal science · 2020
    Review
  18. Gallium(III)-Salophen as a Dual Inhibitor ofACS infectious diseases · 2020
    Article
  19. Article
  20. Dual Inhibition ofACS infectious diseases · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Seoung-Ryoung ChoiDepartment of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Bradley E BritiganDepartment of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Prabagaran NarayanasamyDepartment of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA p.narayanasamy@unmc.edu.
University of Nebraska Medical Center · USUnityPoint Health · US

Funding

Development of Gallium-Based Therapies for Pulmonary Mycobacterial InfectionsI01BX002504 · VA · OMAHA VA MEDICAL CENTER · PI BRITIGAN, BRADLEY E · 2015 to 2018
–
BLRD VA I01 BX002504
6 · The paper itself

Abstract

Iron/heme acquisition systems are critical for microorganisms to acquire iron from the human host, where iron sources are limited due to the nutritional immune system and insolubility of the ferric form of iron. Prior work has shown that a variety of gallium compounds can interfere with bacterial iron acquisition. This study explored the intra- and extracellular antimicrobial activities of gallium protoporphyrin (GaPP), gallium mesoporphyrin (GaMP), and nanoparticles encapsulating GaPP or GaMP against the Gram-negative pathogens

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsBiofilmsCells, CulturedGalliumHemeHumansIronMicrobial Sensitivity TestsNanoparticlesProtoporphyrinsPseudomonas aeruginosaTHP-1 CellsAnti-Bacterial AgentsGalliumHemeIronprotoporphyrin IXProtoporphyrinsAcinetobacter baumanniigalliumheme uptakeiron metabolismnanoparticlePseudomonas aeruginosa

Identifiers

PMID30782994
PMCPMC6437536
OpenAlexW2911982667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.